[{"id":470,"date":"2025-04-08T12:04:34","slug":"lifemine-announces-first-participant-dosed-in-first-in-human-phase-1-clinical-trial-of-life-001","type":"post","link":"https:\/\/lifeminetx.com\/press-releases\/lifemine-announces-first-participant-dosed-in-first-in-human-phase-1-clinical-trial-of-life-001\/","title":{"rendered":"LifeMine Announces First Participant Dosed in First-in-human Phase 1 Clinical Trial of LIFE-001, Designed De Novo to Become a Field Dominating Immunosuppressive for Immune-mediated Disorders and Transplantation"},"excerpt":{"rendered":"","protected":false},"categories":[13]},{"id":452,"date":"2024-09-26T09:00:56","slug":"genomic-discovery-and-structure-activity-exploration-of-a-novel-family-of-enzyme-activated-covalent-cyclin-dependent-kinase-inhibitors","type":"post","link":"https:\/\/lifeminetx.com\/publications\/genomic-discovery-and-structure-activity-exploration-of-a-novel-family-of-enzyme-activated-covalent-cyclin-dependent-kinase-inhibitors\/","title":{"rendered":"Genomic Discovery and Structure\u2013Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors"},"excerpt":{"rendered":"","protected":false},"categories":[14]}]